Personal Genome Diagnostics (PGDx) develops comprehensive genomic profiling solutions for oncology, enabling clinicians and labs to rapidly detect actionable genomic alterations in solid tumors and liquid biopsies. Founded in 2010 by Johns Hopkins researchers, PGDx's elio portfolio includes tissue and plasma CGP solutions used in laboratories worldwide to close the precision oncology gap.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountFeb 2022
Feb 2021
Oct 2018
Jan 2018
Oct 2015
Jan 2014
Create a free account to see which investors have funded this company.
Create Free Account
Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
